Unlocking Novel E3 Ligases with an E3-Agnostic Discovery Platform to Expand Degrader Space

  • Leveraging the RaPPIDSTM platform to accelerate degrader discovery via high-throughput synthesis and phenotypic screening
  • Identifying and functionally characterizing proprietary ligands that engage underexplored E3 ligases
  • Enabling expansion of E3 ligase usage to unlock new biological space and accelerate pipeline progression